(PharmaNewsWire.Com, September 16, 2017 ) Coagulation testing defines a set of methods for checking the hemostasis systems. Hemostasis is the process in which bleeding is stopped from a blood vessel. Coagulometer is used in the medical laboratories to analyze coagulation systems. Many of the methods used in laboratories today were developed more than fifty years ago.
All the methods for analysing coagulation systems can broadly be divided into two types, global tests and local tests. Global tests generate results for the whole clotting cascade. Examples of global tests include Thrombodynamics test, Thrombin generation test and Thromboelastography. They play a pivotal role in the primary phase of diagnostics by generating a detailed analysis of the coagulation cascade. Local tests generate the results of different components of blood coagulation cascade. Examples of local testing include Prothrombin time test and Partial Thromboplastin time.
The Europe Coagulation/Hemostasis Analyzer market is driven by rising geriatric population, poor lifestyle choices, increasing number of people suffering from chronic blood disorders, rising incidence of chronic diseases and increase of foreign investments among others. Huge expansion of hospitals and healthcare centres is also propelling the growth of this market in the region.
The Europe Coagulation/Hemostasis Analyzer market is divided on the basis of test into ACT, aPTT, d dimer testing, platelet function test, prothrombin time testing, anti-factor Xa test, heparin and protamine dose response test for ACT, fibrinogen testing and other coagulation tests. Prothrombin time testing has the largest market share in this segment and is also the fastest growing due to increasing automation of this process in laboratories. On the basis of product, the market is divided into PoC testing analyzers and clinical laboratory analyzers. Clinical laboratory analyzers has the largest market in this segment. By end users, the market is categorized into clinical laboratories, PoC and others. Clinical laboratories has the largest share in the segment. By technology, the market is segmented into electrochemical, optical, mechanical and other technologies. Optical segment has the largest market share and is also the fastest growing in this segment.
The Europe Coagulation/Hemostasis Analyzer market is divided based on geography into United Kingdom, France, Germany and Italy. Europe has the second largest market in the world followed by North America. Factors such as rising geriatric population and rising foreign investments is expected to propel the growth of this market in the region.
Some of the major players in the market include Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), International Technidyne Corporation (U.S.), Nihon Kohden Corporation (Japan) and Diagnostica Stago (France)
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
